Unfortunately, the dosage information in figure 1⇓ of the above article was presented incorrectly. The figure should have appeared as seen below.
FIGURE 1.
Omalizumab dosing table (European Union). Ig: immunoglobulin; Q4 weeks: total dose to be administered every 4 weeks; Q2 weeks: half of total dose to be administered every 2 weeks.
- © ERSJ Ltd
Vol 16 Issue 106
Table of Contents
“WHICH PATIENTS SHOULD BE TREATED WITH ANTI-IGE?”. K-M. BEEH. EUR RESPIR REV 2007; 16: 104, 85–87.
